(Q43165981)

15 November 2017

title

Clinical pharmacokinetics of pregabalin in healthy volunteers (English)

1 reference

15 November 2017

1 reference

Howard N Bockbrader

1

1 reference

15 November 2017

Louis L Radulovic

2

1 reference

15 November 2017

Edward L Posvar

3

1 reference

15 November 2017

James C Strand

4

1 reference

15 November 2017

Christine W Alvey

5

1 reference

15 November 2017

Janice A Busch

6

1 reference

15 November 2017

Edward J Randinitis

7

1 reference

15 November 2017

Brian W Corrigan

8

1 reference

15 November 2017

George M Haig

9

1 reference

15 November 2017

Rebecca A Boyd

10

1 reference

15 November 2017

David L Wesche

11

1 reference

15 November 2017

publication date

10 February 2010

1 reference

The Journal of Clinical Pharmacology

15 November 2017

published in

1 reference

15 November 2017

volume

50

1 reference

15 November 2017

issue

8

1 reference

15 November 2017

page(s)

941-950

1 reference

The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel

15 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352087

Inhibition of K(+)-evoked glutamate release from rat neocortical and hippocampal slices by gabapentin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352087

Inhibition of neuronal Ca(2+) influx by gabapentin and pregabalin in the human neocortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352087

Gabapentin inhibits the substance P-facilitated K(+)-evoked release of [(3)H]glutamate from rat caudial trigeminal nucleus slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352087

Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352087

Systemic gabapentin and S(+)-3-isobutyl-gamma-aminobutyric acid block secondary hyperalgesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352087

Characterization of the effects of gabapentin and 3-isobutyl-gamma-aminobutyric acid on substance P-induced thermal hyperalgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352087

Potent and stereospecific anticonvulsant activity of 3-isobutyl GABA relates to in vitro binding at a novel site labeled by tritiated gabapentin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352087

Pregabalin may represent a novel class of anxiolytic agents with a broad spectrum of activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352087

Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352087

Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352087

Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352087

Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352087

Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352087

Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352087

Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352087

Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352087

Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352087

Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352087

Efficacy of pregabalin in the treatment of generalized anxiety disorder: double-blind, placebo-controlled comparison of BID versus TID dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352087

Pregabalin in generalized anxiety disorder: a placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352087

Efficacy of the novel anxiolytic pregabalin in social anxiety disorder: a placebo-controlled, multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352087

Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352087

A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352087

Drug, meal and formulation interactions influencing drug absorption after oral administration. Clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352087

Effects of food on clinical pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352087

Brain microdialysis and PK/PD correlation of pregabalin in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352087

Pharmacokinetics of pregabalin in subjects with various degrees of renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352087

21 January 2018

Identifiers

DOI

10.1177/0091270009352087

1 reference

15 November 2017

1 reference